Winner Profile
Dr. Pamela Louise Makin
CEO, BTG
Industry: Pharmaceuticals
Company size: Large
Published: 2017-07-24
Is BTG a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Dr. Pamela Louise Makin (BTG) earned the following Obermatt pins for the management performance.
Obermatt accolades Dr. Pamela Louise Makin
| Year | Pin | Category |
|---|---|---|
| 2017 |  |
Growth Performance |
|
Combined Performance | |
| 2016 |  |
Operating Performance |
 |
Combined Performance | |
|
Growth Performance | |
|
Investment Performance |
Dr. Pamela Louise Makin was included in the competition among UK 200 Ranking (United Kingdom) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Dr. Pamela Louise Makin
In summary, Dr. Pamela Louise Makin obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 72 in Combined Performance indicates that Dr. Pamela Louise Makin was better than 72% of all other CEOs that were analyzed as part of the UK 200 Ranking – United Kingdom for two participations in Obermatt CEO competitions. Dr. Pamela Louise Makin’s average ranking can be found in the Multi-Year Rankings for UK 200 Ranking - United Kingdom.